228
Participants
Start Date
August 31, 2007
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
Keppra XR
Administered as two 500 mg tablets (1000 mg) and two placebo tablets once daily for 18 weeks
Keppra XR
Administered as four 500 mg tablets (2000 mg) once daily for 18 weeks
Dothan
Northport
Phoenix
Little Rock
Bakersfield
Jacksonville
Loxahatchee Groves
Atlanta
Suwanee
Winfield
Witchita
Shreveport
Bethesda
Detroit
Camden
New Brunswick
Buffalo
Cedarhurst
Toledo
Tulsa
Bend
Monaca
Philadelphia
Beaufort
Monterrey
Aguascalientes
Distrio Federal
Guadalajara
Guadalajara Jalisco
Mexico City
Monterrey
Bialystok
Gdansk
Katowice
Lodz
Lublin
Poznan
Szczecin
Warsaw
Kalingrad
Kazan'
Moscow
Saint Petersburg
Samara
Yaroslavl
Lead Sponsor
UCB Pharma
INDUSTRY